A great deal of work is being conducted to better define the molecular phenotype of the
individual subsets of JIA and to identify potential new targets for therapeutic interventions …

Background To our knowledge, the characteristics and burden of childhood arthritis have
never been studied on a worldwide basis. We aimed to investigate, with a cross-sectional …

Objective To develop and validate new Juvenile Arthritis Disease Activity Score 10
(JADAS10) and clinical JADAS10 (cJADAS10) cutoffs to separate the states of inactive …

Objective To compare the long-term disease state, in terms of activity and damage, of
children with juvenile idiopathic arthritis (JIA) who had their disease onset in methotrexate …

Pain is the major symptom of children with juvenile idiopathic arthritis (JIA) and its reduction
is a key goal of treatment. It is widely agreed that assessment of pain is a fundamental …

Objective. The current Juvenile Idiopathic Arthritis (JIA) Core Set used in randomized
controlled trials (RCT) and longitudinal observational studies (LOS) was developed without …

Over the past two decades, the management of juvenile idiopathic arthritis (JIA) has been
revolutionized by the increased tendency toward early aggressive interventions and the …

Objective To compare the frequency of joint and tendon disease on ultrasound (US) and
clinical examination, and to investigate agreement between US and clinical evaluation in …

Macrophage activation syndrome (MAS) is a serious, potentially life‐threatening,
hyperinflammatory condition, which belongs to the spectrum of hemophagocytic …

Objective To investigate the frequency in which the physician provides a global assessment
of disease activity (PhGA)> 0 and an active joint count (AJC)= 0 in children with juvenile …